The Centers for Medicare and Medicaid Services will not begin sending out invoices for price inflation rebates owed by manufacturers on Parts B and D drugs until 2025 even though rebate liability has already begun, according to the agency.
The delay in releasing invoices is allowed by the Inflation Reduction Act, which established the rebate program, and will give CMS time to set up the appropriate systems for managing...